These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18810765)

  • 21. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
    Lapis K
    Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-defensins in the gastrointestinal tract.
    Cunliffe RN
    Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
    Wehkamp J; Harder J; Weichenthal M; Mueller O; Herrlinger KR; Fellermann K; Schroeder JM; Stange EF
    Inflamm Bowel Dis; 2003 Jul; 9(4):215-23. PubMed ID: 12902844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
    Bevins CL
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G173-6. PubMed ID: 16014978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate antimicrobial host defense in small intestinal Crohn's disease.
    Koslowski MJ; Beisner J; Stange EF; Wehkamp J
    Int J Med Microbiol; 2010 Jan; 300(1):34-40. PubMed ID: 19850516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J; Schmid M; Stange EF
    Curr Opin Gastroenterol; 2007 Jul; 23(4):370-8. PubMed ID: 17545771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paneth cell defensins: key effector molecules of innate immunity.
    Bevins CL
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):263-6. PubMed ID: 16545089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.
    Fahlgren A; Hammarström S; Danielsson A; Hammarström ML
    Clin Exp Immunol; 2003 Jan; 131(1):90-101. PubMed ID: 12519391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human defensins in Crohn's disease.
    Wehkamp J; Fellermann K; Stange EF
    Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease.
    Beisner J; Teltschik Z; Ostaff MJ; Tiemessen MM; Staal FJ; Wang G; Gersemann M; Perminow G; Vatn MH; Schwab M; Stange EF; Wehkamp J
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G487-98. PubMed ID: 24994854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia.
    Frye M; Bargon J; Lembcke B; Wagner TO; Gropp R
    Eur J Clin Invest; 2000 Aug; 30(8):695-701. PubMed ID: 10964161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.
    Wehkamp J; Chu H; Shen B; Feathers RW; Kays RJ; Lee SK; Bevins CL
    FEBS Lett; 2006 Oct; 580(22):5344-50. PubMed ID: 16989824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease.
    Wehkamp J; Stange EF
    Front Immunol; 2020; 11():646. PubMed ID: 32351509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.
    Kübler I; Koslowski MJ; Gersemann M; Fellermann K; Beisner J; Becker S; Rothfuss K; Herrlinger KR; Stange EF; Wehkamp J
    Aliment Pharmacol Ther; 2009 Sep; 30(6):621-33. PubMed ID: 19549264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Natural immunologic function of Paneth cells in small intestine of patients with Crohn's disease].
    Maemoto A
    Hokkaido Igaku Zasshi; 2004 Mar; 79(2):129-36. PubMed ID: 15101188
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
    Koslowski MJ; Teltschik Z; Beisner J; Schaeffeler E; Wang G; Kübler I; Gersemann M; Cooney R; Jewell D; Reinisch W; Vermeire S; Rutgeerts P; Schwab M; Stange EF; Wehkamp J
    PLoS Genet; 2012; 8(2):e1002523. PubMed ID: 22393312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease.
    Wang G; Stange EF; Wehkamp J
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.